Related Experiment Video
Updated: Jun 1, 2026
09:21
Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons
Published on: July 7, 2023
Molecular insights into Parkinson's disease
1Department of Neurology and Neuroscience, Weill Medical College of Cornell University 525 East 68th Street, A-501, New York, NY 10065 USA.
F1000 Medicine Reports
|June 10, 2011
Summary
Recent genetic discoveries are shedding light on the causes of Parkinson's disease (PD), a neurodegenerative disorder. Understanding these genetic links offers new hope for developing effective neuroprotective therapies.
Area of Science:
- Neuroscience
- Genetics
- Neurology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder affecting movement and autonomic functions due to dopamine neuron loss.
- The precise causes of Parkinson's disease are not fully understood, limiting therapeutic development.
- Recent genetic findings offer new insights into PD pathogenesis.
Purpose of the Study:
- To review recent genetic discoveries in Parkinson's disease.
- To highlight the significance of these genetic advances in understanding disease mechanisms.
- To explore the potential for developing novel neuroprotective therapies for Parkinson's disease.
Main Methods:
- Literature review of recent genetic studies in Parkinson's disease.
- Analysis of identified genes associated with heritable forms of PD.
- Discussion of the implications of genetic findings for disease pathogenesis and therapeutic strategies.
Main Results:
- Identification of specific genes linked to hereditary Parkinson's disease.
- These genetic discoveries provide crucial clues to the underlying mechanisms of PD.
- Advances in genetic research are paving the way for innovative therapeutic approaches.
Conclusions:
- Genetic research has significantly advanced the understanding of Parkinson's disease.
- Understanding genetic links is key to unraveling common disease mechanisms.
- These insights are vital for developing effective neuroprotective treatments for Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...